Related Experiment Video
Updated: May 29, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Transcriptional repression of the tumor suppressor DRO1 by AIB1
Juan Ferragud1, Alvaro Avivar-Valderas, Antoni Pla
1Laboratory of Cellular and Molecular Biology, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
Abstract:
Using transcriptomic gene expression profiling we found tumor suppressor DRO1 being repressed in AIB1 transgenic mice. In agreement, AIB1 represses DRO1 promoter and its expression levels inversely correlate with DRO1 in several cancer cell lines and in ectopic and silencing assays. Estrogen modulators treatment showed a regulation in an estrogen receptor-dependent fashion. Importantly, DRO1 overexpression resulted in BCLAF1 upregulation, a compelling concept given that BCLAF1 is a death-promoting transcriptional repressor. Additionally, DRO1 shuttles from Golgi to the endoplasmic reticulum upon apoptotic stimuli, where it is predicted to facilitate the apoptosis cascade. Finally, DRO1 repression is an important factor for AIB1-mediated inhibition of apoptosis. Collectively, our results reveal DRO1 as an AIB1-targeted tumor suppressor, providing a novel mechanism for AIB1-dependent inhibition of apoptosis.
Insights
Tumor suppressor DRO1 is repressed by AIB1, inhibiting apoptosis. Restoring DRO1 levels may offer a novel therapeutic strategy against AIB1-driven cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Amplification of Integrated Biallelic protein 1 (AIB1) is implicated in various cancers.
- The tumor suppressor DRO1's role in AIB1-mediated oncogenesis is not well understood.
Purpose of the Study:
- To investigate the regulatory relationship between AIB1 and DRO1.
- To elucidate the mechanism by which AIB1 influences apoptosis.
Main Methods:
- Transcriptomic gene expression profiling
- Reporter assays
- Ectopic expression and silencing studies
- Immunofluorescence microscopy
Main Results:
- AIB1 was found to repress DRO1 expression and its promoter activity.
- DRO1 levels inversely correlated with AIB1 in cancer cell lines.
- DRO1 overexpression led to BCLAF1 upregulation and facilitated apoptosis.
- DRO1 shuttles to the endoplasmic reticulum upon apoptotic stimuli.
Conclusions:
- DRO1 acts as a tumor suppressor targeted by AIB1.
- AIB1 inhibits apoptosis by repressing DRO1.
- Targeting the AIB1-DRO1 axis presents a potential therapeutic avenue.
Related Concept Videos
Experimental RNAi
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Negative Regulator Molecules
